دورية أكاديمية

Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.

التفاصيل البيبلوغرافية
العنوان: Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.
المؤلفون: Caballero, Luis, Ruiz-Nodar, Juan M., Marín, Francisco, Roldán, Vanessa, Hurtado, Jose A., Valencia, Jose, Manzano-Fernandez, Sergio, Sogorb, Francisco, Valdes, Mariano, Lip, Gregory Y. H.
المصدر: Age & Ageing; Jan2013, Vol. 42 Issue 1, p70-75, 6p, 4 Charts, 1 Graph
مصطلحات موضوعية: ANTICOAGULANTS, ADVERSE health care events, ATRIAL fibrillation, COMBINATION drug therapy, CHI-squared test, CONFIDENCE intervals, REPORTING of diseases, EPIDEMIOLOGY, FISHER exact test, MYOCARDIAL revascularization, ORAL drug administration, SCALES (Weighing instruments), STATISTICAL hypothesis testing, SURGICAL stents, SURVIVAL analysis (Biometry), T-test (Statistics), TRANSLUMINAL angioplasty, U-statistics, DATA analysis, MULTIPLE regression analysis, CONTROL groups, PROPORTIONAL hazards models, RETROSPECTIVE studies, DATA analysis software, DESCRIPTIVE statistics, KAPLAN-Meier estimator, OLD age
مستخلص: Background: a significant proportion of octogenarian patients with atrial fibrillation (AF) undergo percutaneous coronary intervention (PCI) with stenting. Dual antiplatelet therapy is recommended in these patients, requiring a period of triple therapy with dual antiplatelet agent plus oral anticoagulation (OAC). Concerns remain regarding the appropriateness of OAC in octogenarians.Methods: we reviewed 604 patients (15.7% ≥80 years) with AF undergoing PCI. Clinical follow-up was performed, recording any bleeding episode, thrombo-embolism and major adverse cardiac events (MACE = death, acute myocardial infarction and/or revascularisation of target lesion). We compared octogenarian patients in relation to treatment with OAC at discharge. A secondary aim was to compare octogenarian patients with non-octogenarian patients in terms of their clinical and demographic characteristics, management and clinical outcome.Results: among the 604 patients, 95(15.7%) were aged ≥80 years. Octogenarians had a higher median CHADS2 score (2.78 versus 2.01; P < 0.001) and HAS-BLED score (3.05 versus 2.84; P = 0.028). After a follow-up of 17 ± 14 months, all-cause death occurred in 33%, MACE in 44%, and major bleeding in 21%. OAC was associated with less MACE (28.9 versus 58.3%; P = 0.012) and a similar rate of major bleeding. On multivariable analysis, non-use of OAC at discharge was associated with increased MACE (OR = 4.3; 95% CI = 1.3–14.6; P = 0.02).Conclusion: octogenarian AF patients undergoing PCI/stenting have a high mortality rate and MACE, which can be reduced by means of OAC therapy. [ABSTRACT FROM PUBLISHER]
Copyright of Age & Ageing is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00020729
DOI:10.1093/ageing/afs121